Efficacy and safety of complement inhibitors in patients with geographic atrophy associated with age-related macular degeneration: a network meta-analysis of randomized controlled trials
ImportanceClinical trials in recent years have shown significant effectiveness of complement inhibitors for geographic atrophy (GA) treatment. Two complement inhibitor drugs have been approved by the Food and Drug Administration (FDA).Objectiveto compare and rank the different complement inhibitors...
Saved in:
| Main Authors: | Huan Wang, Jiaqi Zheng, Qing Zhang, Zhongping Tian, Yuhang Sun, Tianyi Zhu, Yanlong Bi, Li Zhang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-11-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1410172/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Outcomes in Pre-Existing Neovascular Age-Related Macular Degeneration Subjects Undergoing Avacincaptad Therapy for Geographic Atrophy
by: Rush RB, et al.
Published: (2024-12-01) -
Real-World Outcomes with Complement Inhibitors for Geographic Atrophy: A Comparative Study of Pegacetacoplan versus Avacincaptad Pegol
by: Rush RB, et al.
Published: (2025-03-01) -
One-Year Outcomes in Subjects Developing Macular Neovascularization While Undergoing Avacincaptad Pegol Therapy for Geographic Atrophy
by: Rush RB, et al.
Published: (2025-01-01) -
Electrophysiological signs of retinal cone remodeling in geographic atrophy of the pigment epithelium in patients with non-exudative age-related macular degeneration
by: N. V. Neroeva, et al.
Published: (2021-09-01) -
Investigating Macular Tissue Integrity Index as a Novel Biomarker in Geographic Atrophy
by: Bethany M. Erb, MD, et al.
Published: (2025-11-01)